tetradecanoylphorbol acetate and liraglutide

tetradecanoylphorbol acetate has been researched along with liraglutide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Dai, Y; Mehta, JL	1
Dai, D; Dai, Y; Ding, Z; Mehta, JL; Wang, X	1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and liraglutide

Article	Year
Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation. Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:5 Topics: Cells, Cultured; Endothelin-1; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; Liraglutide; NF-kappa B; Nitric Oxide Synthase Type III; Receptors, Glucagon; Tetradecanoylphorbol Acetate	2013
DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway. Cardiovascular drugs and therapy, 2014, Volume: 28, Issue:5 Topics: Carrier Proteins; Cell Culture Techniques; Cyclic AMP-Dependent Protein Kinases; Dipeptidyl-Peptidase IV Inhibitors; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Inflammasomes; Interleukin-1beta; Liraglutide; Macrophages; Nitriles; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphorylation; Protein Kinase C; Pyrazines; Pyrrolidines; Receptors, Glucagon; Signal Transduction; Sitagliptin Phosphate; Tetradecanoylphorbol Acetate; Toll-Like Receptor 4; Triazoles	2014

Article

Year

Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation.

Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:5

Topics: Cells, Cultured; Endothelin-1; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; Liraglutide; NF-kappa B; Nitric Oxide Synthase Type III; Receptors, Glucagon; Tetradecanoylphorbol Acetate

2013

DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway.

Cardiovascular drugs and therapy, 2014, Volume: 28, Issue:5

Topics: Carrier Proteins; Cell Culture Techniques; Cyclic AMP-Dependent Protein Kinases; Dipeptidyl-Peptidase IV Inhibitors; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Inflammasomes; Interleukin-1beta; Liraglutide; Macrophages; Nitriles; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphorylation; Protein Kinase C; Pyrazines; Pyrrolidines; Receptors, Glucagon; Signal Transduction; Sitagliptin Phosphate; Tetradecanoylphorbol Acetate; Toll-Like Receptor 4; Triazoles

2014